Peripheral sensory neuropathy (64%), nausea (48%), liver dysfunction (increased aspartate aminotransferase and alanine aminotransferase in 46 and 35%, respectively), and hand-foot syndrome (30%) were comparatively frequent non-hematotoxic adverse events. This evidence concerns the gene GPT and sensory peripheral neuropathy.